KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
South Korea · Delayed Price · Currency is KRW 10,840
-240 (-2.17%)
At close: May 11, 2026
KOREA PHARMA Market Cap
KOREA PHARMA has a market cap or net worth of 118.23 billion as of May 11, 2026. Its market cap has decreased by -20.76% in one year.
Market Cap
118.23B
Enterprise Value
129.64B
Revenue
87.60B
Ranking
n/a
PE Ratio
n/a
Stock Price
10,840.00
Market Cap Chart
Since August 10, 2020, KOREA PHARMA's market cap has decreased from 183.78B to 118.23B, a decrease of -35.67%. That is a compound annual growth rate of -7.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 120.85B | -14.77% |
| Dec 30, 2025 | 141.79B | -15.09% |
| Dec 30, 2024 | 166.98B | -35.26% |
| Dec 28, 2023 | 257.94B | 10.51% |
| Dec 29, 2022 | 233.40B | -55.92% |
| Dec 30, 2021 | 529.52B | 118.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyung Dong Pharmaceutical | 149.26B |
| PHARMARESEARCH BIO | 146.33B |
| Cosmax Nbt | 139.57B |
| DongKoo Bio & Pharma | 134.94B |
| HYUNDAI BIOLAND | 134.25B |
| Organoidsciences | 130.13B |
| H.PIO | 114.13B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 112.61B |